223797-25-9 Usage
Type of compound
Heterocyclic compound
Structural components
Contains a pyridazine ring and a homopiperazine ring
Industry application
Pharmaceutical industry
Usage
Building block for the synthesis of potential drug candidates
Therapeutic applications
Potential ligand for certain receptors in the central nervous system
Research focus
Development of new medications for the treatment of neurological disorders
Current status
Ongoing research in the field of medicinal chemistry
Potential
Holds promise for the development of novel pharmaceuticals
Check Digit Verification of cas no
The CAS Registry Mumber 223797-25-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,7,9 and 7 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 223797-25:
(8*2)+(7*2)+(6*3)+(5*7)+(4*9)+(3*7)+(2*2)+(1*5)=149
149 % 10 = 9
So 223797-25-9 is a valid CAS Registry Number.
223797-25-9Relevant academic research and scientific papers
Heteroaryl diazacycloalkanes, their preparation and use;
-
Page/Page column 22, (2010/11/30)
The present invention discloses compounds of the formula any of its enantiomers or any mixture thereof, isotopes thereof or a pharmaceutically acceptable salt thereof; wherein n is 1, 2 or 3; m is 0, 1 or 2; R represents hydrogen, alkyl, cycloalkyl, cyclo
Heteroaryl diazacycloalkanes, their preparation and use
-
, (2008/06/13)
The present invention relates to novel heteroaryl diazacycloalkane derivatives which are found to be cholinergic ligands at the nicotinic Acetyl Choline Receptors. Due to their pharmacological profile the compounds of the invention may be useful for the t
